pdufa.bio
HomeReadouts › February 2027

February 2027 clinical-trial readouts

trial-readout estimates for February 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← January 2027March 2027 →
22 readouts
SXTP · Feb 2027 (est.)
Tafenoquine — Chronic Babesiosis
TVRD · Feb 2027 (est.)
TTI-101 — Hepatocellular Carcinoma
ABCL · Feb 2027 (est.)
LY3819253 — Vasomotor Symptoms Associated With Menopause
AMLX · Feb 2027 (est.)
AMX0035 — ALS
SNDX · Feb 2027 (est.)
Revumenib — Acute Myeloid Leukemias
NBIX · Feb 2027 (est.)
NBI-1065845 — Tardive Dyskinesia
MRK · Feb 2027 (est.)
Pembrolizumab — Triple Negative Breast Cancer
ENLV · Feb 2027 (est.)
Allocetra — Primary Knee Osteoarthritis
GERN · Feb 2027 (est.)
Imetelstat — Myelofibrosis
GNLX · Feb 2027 (est.)
olvimulogene nanivacirepvec — Advanced Non-squamous Non-small-cell Lung Cancer
IRON · Feb 2027 (est.)
DISC-1459 — Polycythemia Vera (PV)
KOD · Feb 2027 (est.)
KSI-101 — Macular Edema Secondary to Inflammation
KRYS · Feb 2027 (est.)
KB803 — Lung Cancer, Non-small Cell
KYTX · Feb 2027 (est.)
Standard of Care Treatment — Idiopathic Inflammatory Myopathies
MLTX · Feb 2027 (est.)
Sonelokimab — Arthritis, Psoriatic
OCGN · Feb 2027 (est.)
OCU410ST — Retinitis Pigmentosa
NBIX · Feb 2027 (est.)
NBI-1065845 — Trichotillomania (Hair-Pulling Disorder)
NVCR · Feb 2027 (est.)
Temozolomide — Spinal Metastasis
AZN · Feb 2027 (est.)
R-Chop — Diffuse Large B-Cell Lymphoma
ARDX · Feb 2027 (est.)
Tenapanor — Chronic Idiopathic Constipation (CIC)
SGP · Feb 2027 (est.)
Bimatoprost Implant System — Glaucoma
FBRX · Feb 2027 (est.)
FB102 — Celiac Disease
Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).